Find A Portfolio/Ticker
Comparison Box
DGHCX: Allianz RCM Wellness D (MUTUAL FUND)
Basic Info
Asset Class: | Health |
MyPlanIQ Rating: | (25%) |
Start Date: | 03/11/1999 |
Last Dividend Date: | 12/11/2014 |
12-Mo. Yield | 7.12% |
Expenses | 1.46% |
Sign up to get fund ranking change alerts |
Performance Analytics (As of 07/31/2020)
Not up-to-date? TryLast 1 Week* | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | Since 03/11/1999 |
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annualized Return(%) | 0.0 | 0.0 | 0.0 | -2.5 | 10.0 | 6.3 | 9.2 | 8.0 | 8.8 | 10.7 | 9.6 | -5.8 | 10.4 | 30.6 | -26.4 | 10.0 | 0.6 | 1.9 | 12.7 | 28.9 | -26.6 | -16.6 | 72.6 | 4.4 |
Sharpe Ratio | NA | -0.17 | 0.31 | 0.29 | 0.18 | NA | 0.2 | 0.46 | 0.42 | 0.45 | 0.64 | -0.23 | 0.63 | 1.63 | -0.92 | 0.58 | -0.26 | -0.02 | 0.9 | 1.64 | -1.13 | -0.72 | 1.79 | 0.07 |
Draw Down(%) | NA | 17.6 | 19.4 | 23.0 | 40.3 | NA | 49.4 | 17.6 | 16.9 | 19.4 | 12.7 | 23.0 | 13.7 | 17.1 | 38.4 | 5.6 | 12.4 | 8.8 | 13.8 | 8.2 | 35.6 | 32.5 | 36.1 | 17.4 |
Standard Deviation(%) | NA | 25.1 | 24.2 | 23.8 | 22.4 | NA | 22.4 | 20.1 | 20.8 | 23.6 | 15.0 | 25.2 | 16.4 | 18.7 | 29.8 | 12.2 | 10.4 | 11.9 | 13.1 | 17.1 | 24.5 | 26.5 | 38.3 | 30.9 |
Treynor Ratio | NA | -0.04 | 0.06 | 0.06 | 0.04 | NA | 0.04 | 0.08 | 0.08 | 0.09 | 0.08 | -0.05 | 0.09 | 0.33 | -0.28 | 0.07 | -0.03 | 0.0 | 0.1 | 0.25 | -0.24 | -0.13 | 0.59 | 0.02 |
Alpha | NA | -0.08 | -0.1 | -0.09 | -0.05 | NA | -0.03 | 0.0 | -0.07 | -0.13 | -0.03 | -0.07 | 0.01 | 0.04 | -0.04 | 0.02 | -0.04 | -0.05 | 0.01 | 0.0 | -0.06 | -0.02 | 0.02 | 0.01 |
Beta | NA | 1.12 | 1.17 | 1.18 | 1.07 | NA | 1.12 | 1.15 | 1.11 | 1.25 | 1.2 | 1.2 | 1.2 | 0.93 | 0.99 | 1.03 | 1.01 | 1.12 | 1.17 | 1.13 | 1.15 | 1.47 | 1.17 | 1.08 |
RSquared | NA | 0.57 | 0.46 | 0.52 | 0.62 | NA | 0.62 | 0.93 | 0.5 | 0.35 | 0.65 | 0.75 | 0.88 | 0.83 | 0.91 | 0.86 | 0.81 | 0.67 | 0.8 | 0.85 | 0.88 | 0.72 | 0.35 | 0.32 |
Yield(%) | N/A | 13.5 | 15.6 | 12.7 | 7.3 | 4.5 | N/A | 0.0 | 16.7 | 22.1 | 8.8 | 10.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Dividend Growth(%) | N/A | -18.4 | 386.4 | N/A | N/A | N/A | N/A | -100.0 | -18.4 | 177.6 | -19.5 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 03/11/1999
Calculate Performance
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
View Historical Data in an advanced chart |
Use MyPlanIQ Comparison to compare with multiple funds or portfolios |
See Health Asset Class Trend Rankings |
Top Rated Funds in Health
Best Mutual Funds
- VGHCX (VANGUARD HEALTH CARE FUND INVESTOR SHARES) (97%)
- HGHAX (THE HARTFORD HEALTHCARE FUND CLASS A) (78%)
- FSMEX (MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO) (77%)
- FBIOX (BIOTECHNOLOGY PORTFOLIO BIOTECHNOLOGY PORTFOLIO) (77%)
- FBTIX (FIDELITY ADVISOR BIOTECHNOLOGY FUND CLASS I) (77%)
- FPHAX (PHARMACEUTICALS PORTFOLIO PHARMACEUTICALS PORTFOLIO) (75%)
- FSHCX (HEALTH CARE SERVICES PORTFOLIO HEALTH CARE SERVICES PORTFOLIO) (74%)
- FSPHX (HEALTH CARE PORTFOLIO HEALTH CARE PORTFOLIO) (73%)
- FHCIX (FIDELITY ADVISOR HEALTH CARE FUND CLASS I) (73%)
- SHSSX (BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO INSTITUTIONAL) (66%)
Best ETFs
- DRGS (RBS Global Big Pharma ETN) (100%)
- XLV (Health Care Select Sector SPDR® Fund) (96%)
- BBH (VanEck Biotech ETF) (94%)
- IBB (iShares Biotechnology ETF) (94%)
- PPH (VanEck Pharmaceutical ETF) (93%)
- FBT (First Trust NYSE Arca Biotechnology Index Fund) (91%)
- FXH (First Trust Health Care AlphaDEX® Fund) (90%)
- IHE (iShares U.S. Pharmaceuticals ETF) (88%)
- IHF (iShares U.S. Healthcare Providers ETF) (88%)
- IHI (iShares U.S. Medical Devices ETF) (87%)
Best Closed End Funds
- BME (BlackRock Health Sciences Trust) (100%)
- GRX (Gabelli Healthcare & WellnessRx Trust) (99%)
- HQH (Tekla Healthcare Investors) (98%)
- HQL (Tekla Life Sciences Investors) (98%)